Bio-Robot Cancer Therapy Stalled by Regulators | Auckland News

A Whangārei doctor’s revolutionary cancer treatment, OncoRob—a bio-robot that shrinks tumors in terminally ill patients with minimal side effects—is stalled by regulatory hurdles. Medsafe demands costly, multi-stage clinical trials, while the inventors argue their real-world results are compelling and their device doesn’t fit the standard model. A manufacturing certificate alone could cost $200K annually, crippling their small operation. Fears of trade secret exposure under New Zealand’s Official Information Act have halted talks. Yet, the doctor and his nurse wife continue fighting, launching a charitable trust to fund treatments for those who can’t pay—while Medsafe insists all new therapies need rigorous proof before approval. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/fba1579e22825f96